Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Grows By 246.6%

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 213,653 shares, an increase of 246.6% from the May 31st total of 61,636 shares. Based on an average trading volume of 333,674 shares, the days-to-cover ratio is presently 0.6 days. Currently, 1.3% of the shares of the company are sold short.

Azitra Trading Up 0.8%

NYSEAMERICAN:AZTR opened at $0.17 on Friday. The firm’s fifty day simple moving average is $0.21 and its 200 day simple moving average is $0.23. Azitra has a 1 year low of $0.10 and a 1 year high of $1.83.

Azitra (NYSEAMERICAN:AZTR) last announced its earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.24). As a group, equities research analysts predict that Azitra will post -0.25 earnings per share for the current year.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.